Myricetin and Naringenin Inhibit Human Squamous Cell Carcinoma Proliferation and Migration In Vitro

REFERENCES

• Siegel R, Naishadham D, and Jemal A: Cancer statistics. CA Cancer J Clin 62, 10–29, 2012
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Xu J, and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60, 277–300, 2011
   Web of Science ®Google Scholar
• Warnakulasuriya S: Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival. Oral Oncology 46, 407–410, 2010.
   PubMed Web of Science ®Google Scholar
• Noguti J, De Moura CF, De Jesus GP, Da Silva VH, Hossaka TA, et al.: Metastasis from oral cancer: an overview. Cancer Genomics Proteomics, 9, 329–335, 2012.
   PubMed Web of Science ®Google Scholar
• Mascolo M, Siano M, Ilardi G, Russo D, Merolla F, et al.: Epigenetic disregulation in oral cancer. Int J Mol Sci 13, 2331–2353, 2012.
   PubMed Web of Science ®Google Scholar
• Garavello W, Lucenteforte E, Bosetti C, and La Vecchia C: The role of foods and nutrients on oral and pharyngeal cancer risk. Minerva Stomatol 58, 25–34, 2009.
   PubMedGoogle Scholar
• Shiboski CH, Schmidt BL, and Jordan RC: Tongue and tonsilar carcinoma: increasing trends in the US population ages 20–44 years. Cancer 103, 1843–1849, 2005.
   PubMed Web of Science ®Google Scholar
• Romagnolo DF and Selmin OI: Flavonoids and cancer prevention: a review of the evidence. J Nutr Gerontol Geriatr 31, 206–238, 2012.
   PubMedGoogle Scholar
• Benavente-García O and Castillo J: Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem 56, 6185–6205, 2008.
   PubMed Web of Science ®Google Scholar
• Clere N, Faure S, Martinez MC, and Andriantsitohaina R: Anticancer properties of flavonoids: roles in various stages of carcinogenesis. Cardiovasc Hematol Agents Med Chem 9(2), 62–77, 2011.
   PubMedGoogle Scholar
• Kanno S, Tomizawa A, Ohtake T, Koiwai K, Ujibe M, et al.: Naringenin-induced apoptosis via activation of NF-kappaB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells. Toxicol Lett 166, 131–139, 2006.
   PubMed Web of Science ®Google Scholar
• Kanadaswami C, Lung-Ta Lee, Ping-Ping H Lee, Jiuan-Jiuan Hwang, Ferng-chun KE, et al.: The antitumor activities of flavonoids. In Vivo 19, 895–910, 2005.
   PubMed Web of Science ®Google Scholar
• Sabarinathan D, Mahalakshmi P, and Vanisree AJ: Naringenin promote apoptosis in cerebrally implanted C6 glioma cells. Mol Cell Biochem 345, 215–222, 2010.
   PubMed Web of Science ®Google Scholar
• Park JH, Jin CY, Lee BK, Kim GY, Choi YH, et al.: Naringenin induces apoptosis through downregulation of Akt and caspase-3 activation in human leukemia THP-1 cells. Food Chem Toxicol 46, 3684–3690, 2008.
   PubMed Web of Science ®Google Scholar
• Kang NJ, Jung SK, Lee KW, and Lee HJ: Myricetin is a potent chemopreventive phytochemical in skin carcinogenesis. Ann N Y Acad Sci 1229, 124–132, 2011.
   PubMed Web of Science ®Google Scholar
• Ong KC and Khoo HE: Biological effects of myricetin. Gen Pharmacol 29, 121–126, 1997.
   PubMedGoogle Scholar
• Gordon MH and Roedig-Penman A: Antioxidant activity of quercetin and myricetin in liposomes. Chem Phys Lipids 97, 79–85, 1998.
   PubMed Web of Science ®Google Scholar
• Miller EG, Peacock JJ, Bourland TC, Taylor SE, Wright JM, et al.:Inhibition of oral carcinogenesis by citrus flavonoids. Nutr Cancer 60, 69–74, 2008.
   PubMed Web of Science ®Google Scholar
• Tímár J, Csuka O, Remenár E, Répássy G, and Kásler M: Progression of head and neck squamous cell cancer. Cancer Metastasis Review 24, 107–127, 2005.
   PubMed Web of Science ®Google Scholar
• Komissarova EV and Rossman TG: Arsenite induced poly(ADP-ribosyl)ation of tumor suppressor P53 in human skin keratinocytes as a possible mechanism for carcinogenesis associated with arsenic exposure. Toxicol Appl Pharmacol 243, 399–404, 2010.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhao XH, and Wang ZJ: Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis. Toxicol In Vitro 23, 797–807, 2009.
   PubMed Web of Science ®Google Scholar
• Morales P and Haza AI: Selective apoptotic effects of piceatannol and myricetin in human cancer cells. J Appl Toxicol 32, 986–993, 2012.
   PubMed Web of Science ®Google Scholar
• Kim W, Yang HJ, Youn H, Yun YJ, Seong KM, et al.: Myricetin inhibits Akt survival signaling and induces Bad-mediated apoptosis in a low dose ultraviolet (UV)-B-irradiated HaCaT human immortalized keratinocytes. J Radiat Res 51, 285–296, 2010.
   PubMed Web of Science ®Google Scholar
• Jin CY, Park C, Lee JH, Chung KT, Kwon TK, et al.: Naringenin-induced apoptosis is attenuated by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human leukemia U937 cells. Toxicol In Vitro 23, 259–265, 2009.
   PubMed Web of Science ®Google Scholar
• Kanno S, Tomizawa A, Hiura T, Osanai Y, Shouji A, et al.: Inhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice. Biol Pharm Bull 28, 527–530, 2005.
   PubMed Web of Science ®Google Scholar
• Jin CY, Park C, Lee JH, Chung KT, Kwon TK, et al.: Naringenin-induced apoptosis is attenuated by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human leukemia U937 cells. Toxicol In Vitro 23, 259–265, 2009.
   PubMed Web of Science ®Google Scholar
• Phillips PA, Sangwan V, Borja-Cacho D, Dudeja V, Vickers SM, et al.: Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway. Cancer Lett 308, 181–188, 2011.
   PubMed Web of Science ®Google Scholar
• Hsiao YC, Hsieh YS, Kuo WH, Chiou HL, Yang SF, et al.: The tumor-growth inhibitory activity of flavanone and 2’-OH flavanone in vitro and in vivo through induction of cell cycle arrest and suppression of cyclins and CDKs. J Biomed Sci 14, 107–119, 2007.
   PubMed Web of Science ®Google Scholar
• Strobel P, Allard C, Perez-Acle T, Calderon R, Aldunate R, et al.: Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes. Biochem J 386, 471–478, 2005.
   PubMed Web of Science ®Google Scholar
• Lee EJ, Kim DI, Kim WJ, and Moon SK: Naringin inhibits matrix metalloproteinase-9 expression and AKT phosphorylation in tumor necrosis factor-alpha-induced vascular smooth muscle cells. Mol Nutr Food Res 53, 1582–1591, 2009.
   PubMed Web of Science ®Google Scholar
• Kim DI, Lee SJ, Lee SB, Park K, Kim WJ, et al.: Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression. Carcinogenesis 29, 1701–1709, 2008.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhao XH, and Wang ZJ: Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis. Toxicol In Vitro 23, 797–807, 2009.
   PubMed Web of Science ®Google Scholar
• Kumamoto T, Fujii M, and Hou DX: AKT is a direct target for myricetin to inhibit cell transformation. Mol Cell Biochem 332, 33–41, 2009.
   PubMed Web of Science ®Google Scholar
• Shih YW, Wu PF, Lee YC, Shi MD, and Chiang TA: Myricetin suppresses invasion and migration of human lung adenocarcinoma A549 cells: possible mediation by blocking the ERK signaling pathway. J Agric Food Chem 57, 3490–3499, 2009.
   PubMed Web of Science ®Google Scholar
• Lou C, Zhang F, Yang M, Zhao J, Zeng W, et al.: Naringenin decreases invasiveness and metastasis by inhibiting TGF-β-induced epithelial to mesenchymal transition in pancreatic cancer cells. PLoS One 7(12), e50956, 2012.
   PubMed Web of Science ®Google Scholar